FdaApplication

NDA 022037

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date2009-09-02

Products (4)

ProductActive ingredientStrengthDosage form
INTUNIVGUANFACINE HYDROCHLORIDEEQ 2MG BASETABLET, EXTENDED RELEASE;ORAL
INTUNIVGUANFACINE HYDROCHLORIDEEQ 1MG BASETABLET, EXTENDED RELEASE;ORAL
INTUNIVGUANFACINE HYDROCHLORIDEEQ 3MG BASETABLET, EXTENDED RELEASE;ORAL
INTUNIVGUANFACINE HYDROCHLORIDEEQ 4MG BASETABLET, EXTENDED RELEASE;ORAL

4 products